世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

坐骨神経痛治療の世界市場 2023-2027


Global Sciatica Treatment Market 2023-2027

世界の坐骨神経痛治療市場 2023-2027 坐骨神経痛治療市場は、2022年から2027年にかけて3,890億8,000万米ドルの成長が予測され、予測期間中のCAGRは4.83%で加速すると予測されています。この調査レポートは、坐骨... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2023年8月24日 US$2,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
159 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

世界の坐骨神経痛治療市場 2023-2027
坐骨神経痛治療市場は、2022年から2027年にかけて3,890億8,000万米ドルの成長が予測され、予測期間中のCAGRは4.83%で加速すると予測されています。この調査レポートは、坐骨神経痛治療市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。坐骨神経痛に対する意識の高まり、坐骨神経痛の危険因子の有病率の増加、パイプライン医薬品に対する規制当局の支援などが市場を牽引しています。
Technavioの坐骨神経痛治療市場は以下のように区分されています:
エンドユーザー別
- 病院
- 診療所
- その他
製品別
- 非外科的治療
- 外科的治療
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)
本調査では、クロニジンマイクロペレット硬膜外注射の開発が、今後数年間の坐骨神経痛治療市場の成長を牽引する主要な理由の一つであると特定しています。また、坐骨神経痛に関する研究資金の増加や、坐骨神経痛治療のための理学療法に対する意識の高まりは、市場の大きな需要につながるでしょう。
本レポートでは、坐骨神経痛治療市場について以下の領域をカバーしています:
- 坐骨神経痛治療市場のサイジング
- 坐骨神経痛治療市場予測
- 坐骨神経痛治療市場の産業分析
本レポートでは、坐骨神経痛治療市場の主要ベンダーであるAmneal Pharmaceuticals Inc.、Apotex Inc.、Aurobindo Pharma Ltd.、Bayer AG、Dr Reddys Laboratories Ltd.、Elam Pharma Pvt. Ltd.、Fresenius SE and Co.KGaA、Glenmark Pharmaceuticals Ltd.、Hikma Pharmaceuticals Plc、Johnson and Johnson、KOLON LIFE SCIENCE、Lupin Ltd.、Novartis AG、Omega Laser Systems Ltd.、Ozone Pharmaceuticals Ltd.、Pfizer Inc.、Sanofi、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Viatris Inc.また、坐骨神経痛治療市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/sciatica-treatment-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global Sciatica Treatment Market 2023-2027 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global sciatica treatment market 2023-2027 2017 - 2021 ($ billion)
o 4.2 End-user Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
o 4.3 Product Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospital - Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospital - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
o 6.4 Clinics - Market size and forecast 2022-2027
o Exhibit 38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
o 6.5 Others - Market size and forecast 2022-2027
o Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 Non-surgical treatment - Market size and forecast 2022-2027
o Exhibit 52: Chart on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
o 7.4 Surgical treatment - Market size and forecast 2022-2027
o Exhibit 56: Chart on Surgical treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Surgical treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Surgical treatment - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Surgical treatment - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 60: Market opportunity by Product ($ million)
o Exhibit 61: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Canada - Market size and forecast 2022-2027
o Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Apotex Inc.
o Exhibit 111: Apotex Inc. - Overview
o Exhibit 112: Apotex Inc. - Product / Service
o Exhibit 113: Apotex Inc. - Key offerings
o 12.4 Aurobindo Pharma Ltd.
o Exhibit 114: Aurobindo Pharma Ltd. - Overview
o Exhibit 115: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 116: Aurobindo Pharma Ltd. - Key offerings
o 12.5 Bayer AG
o Exhibit 117: Bayer AG - Overview
o Exhibit 118: Bayer AG - Business segments
o Exhibit 119: Bayer AG - Key news
o Exhibit 120: Bayer AG - Key offerings
o Exhibit 121: Bayer AG - Segment focus
o 12.6 Dr Reddys Laboratories Ltd.
o Exhibit 122: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 123: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 124: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 125: Dr Reddys Laboratories Ltd. - Segment focus
o 12.7 Elam Pharma Pvt. Ltd.
o Exhibit 126: Elam Pharma Pvt. Ltd. - Overview
o Exhibit 127: Elam Pharma Pvt. Ltd. - Product / Service
o Exhibit 128: Elam Pharma Pvt. Ltd. - Key offerings
o 12.8 Fresenius SE and Co. KGaA
o Exhibit 129: Fresenius SE and Co. KGaA - Overview
o Exhibit 130: Fresenius SE and Co. KGaA - Business segments
o Exhibit 131: Fresenius SE and Co. KGaA - Key news
o Exhibit 132: Fresenius SE and Co. KGaA - Key offerings
o Exhibit 133: Fresenius SE and Co. KGaA - Segment focus
o 12.9 Glenmark Pharmaceuticals Ltd.
o Exhibit 134: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 135: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 136: Glenmark Pharmaceuticals Ltd. - Key offerings
o 12.10 Hikma Pharmaceuticals Plc
o Exhibit 137: Hikma Pharmaceuticals Plc - Overview
o Exhibit 138: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 139: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 140: Hikma Pharmaceuticals Plc - Segment focus
o 12.11 Johnson and Johnson
o Exhibit 141: Johnson and Johnson - Overview
o Exhibit 142: Johnson and Johnson - Business segments
o Exhibit 143: Johnson and Johnson - Key news
o Exhibit 144: Johnson and Johnson - Key offerings
o Exhibit 145: Johnson and Johnson - Segment focus
o 12.12 Novartis AG
o Exhibit 146: Novartis AG - Overview
o Exhibit 147: Novartis AG - Business segments
o Exhibit 148: Novartis AG - Key offerings
o Exhibit 149: Novartis AG - Segment focus
o 12.13 Omega Laser Systems Ltd.
o Exhibit 150: Omega Laser Systems Ltd. - Overview
o Exhibit 151: Omega Laser Systems Ltd. - Product / Service
o Exhibit 152: Omega Laser Systems Ltd. - Key offerings
o 12.14 Ozone Pharmaceuticals Ltd.
o Exhibit 153: Ozone Pharmaceuticals Ltd. - Overview
o Exhibit 154: Ozone Pharmaceuticals Ltd. - Key offerings
o 12.15 Pfizer Inc.
o Exhibit 155: Pfizer Inc. - Overview
o Exhibit 156: Pfizer Inc. - Product / Service
o Exhibit 157: Pfizer Inc. - Key news
o Exhibit 158: Pfizer Inc. - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 159: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 160: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 163: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Viatris Inc.
o Exhibit 164: Viatris Inc. - Overview
o Exhibit 165: Viatris Inc. - Business segments
o Exhibit 166: Viatris Inc. - Key news
o Exhibit 167: Viatris Inc. - Key offerings
o Exhibit 168: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 169: Inclusions checklist
o Exhibit 170: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 171: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 172: Research methodology
o Exhibit 173: Validation techniques employed for market sizing
o Exhibit 174: Information sources
o 13.5 List of abbreviations
o Exhibit 175: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global sciatica treatment market 2023-2027 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Product - Market share 2022-2027 (%)
Exhibits49: Data Table on Product - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Surgical treatment - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Surgical treatment - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Surgical treatment - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Surgical treatment - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Product ($ million)
Exhibits61: Data Table on Market opportunity by Product ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Apotex Inc. - Overview
Exhibits112: Apotex Inc. - Product / Service
Exhibits113: Apotex Inc. - Key offerings
Exhibits114: Aurobindo Pharma Ltd. - Overview
Exhibits115: Aurobindo Pharma Ltd. - Product / Service
Exhibits116: Aurobindo Pharma Ltd. - Key offerings
Exhibits117: Bayer AG - Overview
Exhibits118: Bayer AG - Business segments
Exhibits119: Bayer AG - Key news
Exhibits120: Bayer AG - Key offerings
Exhibits121: Bayer AG - Segment focus
Exhibits122: Dr Reddys Laboratories Ltd. - Overview
Exhibits123: Dr Reddys Laboratories Ltd. - Business segments
Exhibits124: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits125: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits126: Elam Pharma Pvt. Ltd. - Overview
Exhibits127: Elam Pharma Pvt. Ltd. - Product / Service
Exhibits128: Elam Pharma Pvt. Ltd. - Key offerings
Exhibits129: Fresenius SE and Co. KGaA - Overview
Exhibits130: Fresenius SE and Co. KGaA - Business segments
Exhibits131: Fresenius SE and Co. KGaA - Key news
Exhibits132: Fresenius SE and Co. KGaA - Key offerings
Exhibits133: Fresenius SE and Co. KGaA - Segment focus
Exhibits134: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits135: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits136: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits137: Hikma Pharmaceuticals Plc - Overview
Exhibits138: Hikma Pharmaceuticals Plc - Business segments
Exhibits139: Hikma Pharmaceuticals Plc - Key offerings
Exhibits140: Hikma Pharmaceuticals Plc - Segment focus
Exhibits141: Johnson and Johnson - Overview
Exhibits142: Johnson and Johnson - Business segments
Exhibits143: Johnson and Johnson - Key news
Exhibits144: Johnson and Johnson - Key offerings
Exhibits145: Johnson and Johnson - Segment focus
Exhibits146: Novartis AG - Overview
Exhibits147: Novartis AG - Business segments
Exhibits148: Novartis AG - Key offerings
Exhibits149: Novartis AG - Segment focus
Exhibits150: Omega Laser Systems Ltd. - Overview
Exhibits151: Omega Laser Systems Ltd. - Product / Service
Exhibits152: Omega Laser Systems Ltd. - Key offerings
Exhibits153: Ozone Pharmaceuticals Ltd. - Overview
Exhibits154: Ozone Pharmaceuticals Ltd. - Key offerings
Exhibits155: Pfizer Inc. - Overview
Exhibits156: Pfizer Inc. - Product / Service
Exhibits157: Pfizer Inc. - Key news
Exhibits158: Pfizer Inc. - Key offerings
Exhibits159: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits160: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits161: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits162: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits163: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits164: Viatris Inc. - Overview
Exhibits165: Viatris Inc. - Business segments
Exhibits166: Viatris Inc. - Key news
Exhibits167: Viatris Inc. - Key offerings
Exhibits168: Viatris Inc. - Segment focus
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Sciatica Treatment Market 2023-2027
The sciatica treatment market is forecasted to grow by USD 3089.08 mn during 2022-2027, accelerating at a CAGR of 4.83% during the forecast period. The report on the sciatica treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising awareness about sciatica, growing prevalence of risk factors for sciatica, and regulatory support for pipeline drugs.
Technavio's sciatica treatment market is segmented as below:
By End-user
• Hospital
• Clinics
• Others
By Product
• Non-surgical treatment
• Surgical treatment
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the development of clonidine micropellet epidural injections as one of the prime reasons driving the sciatica treatment market growth during the next few years. Also, increasing funds for research on sciatica and rising awareness of physiotherapy for sciatica treatment will lead to sizable demand in the market.
The report on the sciatica treatment market covers the following areas:
• Sciatica treatment market sizing
• Sciatica treatment market forecast
• Sciatica treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sciatica treatment market vendors that include Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Bayer AG, Dr Reddys Laboratories Ltd., Elam Pharma Pvt. Ltd., Fresenius SE and Co. KGaA, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Johnson and Johnson, KOLON LIFE SCIENCE, Lupin Ltd., Novartis AG, Omega Laser Systems Ltd., Ozone Pharmaceuticals Ltd., Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the sciatica treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/sciatica-treatment-market-industry-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global Sciatica Treatment Market 2023-2027 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global sciatica treatment market 2023-2027 2017 - 2021 ($ billion)
o 4.2 End-user Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
o 4.3 Product Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospital - Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospital - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
o 6.4 Clinics - Market size and forecast 2022-2027
o Exhibit 38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
o 6.5 Others - Market size and forecast 2022-2027
o Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 Non-surgical treatment - Market size and forecast 2022-2027
o Exhibit 52: Chart on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
o 7.4 Surgical treatment - Market size and forecast 2022-2027
o Exhibit 56: Chart on Surgical treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Surgical treatment - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Surgical treatment - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Surgical treatment - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 60: Market opportunity by Product ($ million)
o Exhibit 61: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Canada - Market size and forecast 2022-2027
o Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Apotex Inc.
o Exhibit 111: Apotex Inc. - Overview
o Exhibit 112: Apotex Inc. - Product / Service
o Exhibit 113: Apotex Inc. - Key offerings
o 12.4 Aurobindo Pharma Ltd.
o Exhibit 114: Aurobindo Pharma Ltd. - Overview
o Exhibit 115: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 116: Aurobindo Pharma Ltd. - Key offerings
o 12.5 Bayer AG
o Exhibit 117: Bayer AG - Overview
o Exhibit 118: Bayer AG - Business segments
o Exhibit 119: Bayer AG - Key news
o Exhibit 120: Bayer AG - Key offerings
o Exhibit 121: Bayer AG - Segment focus
o 12.6 Dr Reddys Laboratories Ltd.
o Exhibit 122: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 123: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 124: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 125: Dr Reddys Laboratories Ltd. - Segment focus
o 12.7 Elam Pharma Pvt. Ltd.
o Exhibit 126: Elam Pharma Pvt. Ltd. - Overview
o Exhibit 127: Elam Pharma Pvt. Ltd. - Product / Service
o Exhibit 128: Elam Pharma Pvt. Ltd. - Key offerings
o 12.8 Fresenius SE and Co. KGaA
o Exhibit 129: Fresenius SE and Co. KGaA - Overview
o Exhibit 130: Fresenius SE and Co. KGaA - Business segments
o Exhibit 131: Fresenius SE and Co. KGaA - Key news
o Exhibit 132: Fresenius SE and Co. KGaA - Key offerings
o Exhibit 133: Fresenius SE and Co. KGaA - Segment focus
o 12.9 Glenmark Pharmaceuticals Ltd.
o Exhibit 134: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 135: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 136: Glenmark Pharmaceuticals Ltd. - Key offerings
o 12.10 Hikma Pharmaceuticals Plc
o Exhibit 137: Hikma Pharmaceuticals Plc - Overview
o Exhibit 138: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 139: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 140: Hikma Pharmaceuticals Plc - Segment focus
o 12.11 Johnson and Johnson
o Exhibit 141: Johnson and Johnson - Overview
o Exhibit 142: Johnson and Johnson - Business segments
o Exhibit 143: Johnson and Johnson - Key news
o Exhibit 144: Johnson and Johnson - Key offerings
o Exhibit 145: Johnson and Johnson - Segment focus
o 12.12 Novartis AG
o Exhibit 146: Novartis AG - Overview
o Exhibit 147: Novartis AG - Business segments
o Exhibit 148: Novartis AG - Key offerings
o Exhibit 149: Novartis AG - Segment focus
o 12.13 Omega Laser Systems Ltd.
o Exhibit 150: Omega Laser Systems Ltd. - Overview
o Exhibit 151: Omega Laser Systems Ltd. - Product / Service
o Exhibit 152: Omega Laser Systems Ltd. - Key offerings
o 12.14 Ozone Pharmaceuticals Ltd.
o Exhibit 153: Ozone Pharmaceuticals Ltd. - Overview
o Exhibit 154: Ozone Pharmaceuticals Ltd. - Key offerings
o 12.15 Pfizer Inc.
o Exhibit 155: Pfizer Inc. - Overview
o Exhibit 156: Pfizer Inc. - Product / Service
o Exhibit 157: Pfizer Inc. - Key news
o Exhibit 158: Pfizer Inc. - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 159: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 160: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 163: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Viatris Inc.
o Exhibit 164: Viatris Inc. - Overview
o Exhibit 165: Viatris Inc. - Business segments
o Exhibit 166: Viatris Inc. - Key news
o Exhibit 167: Viatris Inc. - Key offerings
o Exhibit 168: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 169: Inclusions checklist
o Exhibit 170: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 171: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 172: Research methodology
o Exhibit 173: Validation techniques employed for market sizing
o Exhibit 174: Information sources
o 13.5 List of abbreviations
o Exhibit 175: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global sciatica treatment market 2023-2027 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Product - Market share 2022-2027 (%)
Exhibits49: Data Table on Product - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Non-surgical treatment - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Non-surgical treatment - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Surgical treatment - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Surgical treatment - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Surgical treatment - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Surgical treatment - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Product ($ million)
Exhibits61: Data Table on Market opportunity by Product ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Apotex Inc. - Overview
Exhibits112: Apotex Inc. - Product / Service
Exhibits113: Apotex Inc. - Key offerings
Exhibits114: Aurobindo Pharma Ltd. - Overview
Exhibits115: Aurobindo Pharma Ltd. - Product / Service
Exhibits116: Aurobindo Pharma Ltd. - Key offerings
Exhibits117: Bayer AG - Overview
Exhibits118: Bayer AG - Business segments
Exhibits119: Bayer AG - Key news
Exhibits120: Bayer AG - Key offerings
Exhibits121: Bayer AG - Segment focus
Exhibits122: Dr Reddys Laboratories Ltd. - Overview
Exhibits123: Dr Reddys Laboratories Ltd. - Business segments
Exhibits124: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits125: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits126: Elam Pharma Pvt. Ltd. - Overview
Exhibits127: Elam Pharma Pvt. Ltd. - Product / Service
Exhibits128: Elam Pharma Pvt. Ltd. - Key offerings
Exhibits129: Fresenius SE and Co. KGaA - Overview
Exhibits130: Fresenius SE and Co. KGaA - Business segments
Exhibits131: Fresenius SE and Co. KGaA - Key news
Exhibits132: Fresenius SE and Co. KGaA - Key offerings
Exhibits133: Fresenius SE and Co. KGaA - Segment focus
Exhibits134: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits135: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits136: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits137: Hikma Pharmaceuticals Plc - Overview
Exhibits138: Hikma Pharmaceuticals Plc - Business segments
Exhibits139: Hikma Pharmaceuticals Plc - Key offerings
Exhibits140: Hikma Pharmaceuticals Plc - Segment focus
Exhibits141: Johnson and Johnson - Overview
Exhibits142: Johnson and Johnson - Business segments
Exhibits143: Johnson and Johnson - Key news
Exhibits144: Johnson and Johnson - Key offerings
Exhibits145: Johnson and Johnson - Segment focus
Exhibits146: Novartis AG - Overview
Exhibits147: Novartis AG - Business segments
Exhibits148: Novartis AG - Key offerings
Exhibits149: Novartis AG - Segment focus
Exhibits150: Omega Laser Systems Ltd. - Overview
Exhibits151: Omega Laser Systems Ltd. - Product / Service
Exhibits152: Omega Laser Systems Ltd. - Key offerings
Exhibits153: Ozone Pharmaceuticals Ltd. - Overview
Exhibits154: Ozone Pharmaceuticals Ltd. - Key offerings
Exhibits155: Pfizer Inc. - Overview
Exhibits156: Pfizer Inc. - Product / Service
Exhibits157: Pfizer Inc. - Key news
Exhibits158: Pfizer Inc. - Key offerings
Exhibits159: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits160: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits161: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits162: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits163: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits164: Viatris Inc. - Overview
Exhibits165: Viatris Inc. - Business segments
Exhibits166: Viatris Inc. - Key news
Exhibits167: Viatris Inc. - Key offerings
Exhibits168: Viatris Inc. - Segment focus
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る